Moxalactam therapy of serious infections36608

Last updated on 23-8-2019 by Anonymous (non vérifié)

Public Access

Published

Peer reviewed scientific article

SCIENSANO

Résumé:

Twenty-four patients were treated with moxalactam for 25 serious infections. Nineteen patients were septicemic and 18 presented severe underlying diseases considered to impair the normal response to bacterial pathogens. All of the pathogens had MICs of less than 12 mg/l except one Pseudomonas aeruginosa strain with an MIC of 32 mg/l. The dosage ranged from 3 to 12 g/day; the route of administration was either i.v. or i.m. The duration of treatment was six to 26 days. Six patients had urinary tract infections (three bacteremia), four had pulmonary abscesses (two bacteremia), five had septic …

Associated health topics:

QR code

QR code for this page URL